Male factors play a role in about half of all infertility cases, yet men often are not evaluated while their partner goes through fertility treatments. This Q&A with urologist Scott Lundy, MD, PhD, addresses how to advocate for patients.Read More
For the first time, Cleveland Clinic surgeons orchestrated a nearly simultaneous robotic single-port (SP) kidney transplant procedure for a donor and recipient using one robot.
Although genetic testing is becoming increasingly accessible to patients with kidney diseases, little is known about racial disparities in renal genetics evaluations.
HIF-2 alpha inhibitor shows promise for treating refractory clear-cell kidney cancer.
Urologist Hadley Wood, MD, discusses her vision as Urology’s new editor-in-chief and the link between this role, her clinical practice and research program.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic investigators have launched a novel clinical trial to assess the efficacy of low-intensity focused shockwave therapy and radial wave therapy for treatment of erectile dysfunction or chronic pelvic pain in prostate cancer survivors.
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
What new findings reveal about intraoperative sacral neuromodulation lead placement in patients receiving the treatment for overactive bladder.
Cleveland Clinic urology researchers have made a startling discovery that holds major potential for noninvasive treatment of idiopathic male infertility.
Why researchers are hopeful that photonic lithotripsy, an innovative approach to fragmenting kidney stones, could be an alternative for patients who don’t succeed with current interventions.
Aquablation therapy, indicated for men with benign prostatic hyperplasia, is designed to remove tissue with fewer side effects, giving the therapy an advantage over some existing procedures.